The scientific community are rising to the challenge of worldwide vaccination, undertaking a health programme of unprecedented scale
- Pascal Soriot is the chief executive officer of AstraZeneca
Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering across the world. Now more than ever, we must remember that no one is safe until everyone is safe. As the World Health Organization (WHO) director general, Dr Tedros Adhanom Ghebreyesus, has said, a “me first” approach to vaccination won’t defeat Covid.
That is why we at AstraZeneca, working with our partners in the multilateral Covax initiative, are doing all we can to make sure people around the world have access to safe, effective Covid-19 vaccines, wherever they live and regardless of income level. AstraZeneca was the first global pharmaceutical company to lend its support to the initiative and our vaccine will be the single biggest contributor in the first half of this year. I am greatly encouraged that many more companies are joining us in this effort.
